Download Podcasts - Complimentary


 Challenges and Opportunities in Molecular Testing for Infectious Disease
Jennifer Dien Bard, PhD, D(ABMM), Director, Microbiology and Virology, Children’s Hospital Los Angeles; Associate Professor, Pathology and Laboratory Medicine, Keck School of Medicine, University of Southern California

 Dissecting Liquid Biopsy in MBC: CTCs, ctDNA and CAMLs to Evaluate Innate Immunity
Massimo Cristofanilli, MD, FACP, Professor, Medicine; Associate Director, Translational Research and Precision Medicine; Director, OncoSET Precision Medicine Program, Medicine-Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University

 Last Mile of Molecular Diagnostics in Precision Medicine and Healthcare
Bruce Quinn, MD, PhD, Principal, Bruce Quinn Associates

 Rapid Fire: Getting to Know Suman Bose
Suman Bose, PhD, Postdoctoral Fellow, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology

 Looking at the Value of NGS-based Diagnostic Testing for Lung Cancer Patients
Daryl Pritchard, PhD, Professor, Bioengineering, University of Washington

 Developing Low Cost Diagnostics for Infectious Disease – Strategies and Advice
Paul Yager, PhD, Professor, Bioengineering, University of Washington


 Wild West: Exome Sequencing in the Clinic
Avni B. Santani, Ph.D., Assistant Professor, Clinical Pathology, University of Pennsylvania School of Medicine; Scientific Director, Molecular Genetics Laboratory, The Children’s Hospital of Philadelphia

 The Role of Molecular Diagnostics in Antibiotics Stewardships Programs
Elena Grigorenko, Vice President, Research and Development, Diatherix, Eurofins Clinical Diagnostics, LLC

Point-of-Care Devices in Liquid Biopsy
Andrew H. Ko, M.D., Professor, Clinical Medicine, Division of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco

Point-of-Care Devices in Immunotherapy and Beyond
M. Allen Northrup, Ph.D., FRSC, CEO, MIODx

Point-of-Care Devices in Liquid Biopsy
Andrew H. Ko, M.D., Professor, Clinical Medicine, Division of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco

The Microbiome’s Diagnostic Potential in Infectious Disease Point-of-Care Assays
Georgios Kitsios, M.D., Ph.D., Instructor of Medicine; Post-Doctoral Scholar, Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh Medical Center

NGS in DNA Forensics: Benefits, Challenges, and Future Potential
Cassandra D. Calloway, Ph.D., Assistant Scientist and DNA Program Coordinator, Genetics and Genomics and Forensic Graduate Program, Children’s Hospital Oakland Research Institute and University of California, Davis

A Multiplexed Approach for Predicting Responses to Cancer Immunotherapy: Implementation and Challenges
Robert A. Anders, M.D., Ph.D., Associate Professor of Pathology, Division of GI and Liver Pathology, Bloomberg-Kimmel Institute for Cancer Immune Therapy, Johns Hopkins Medicine

Geisinger’s Strategy for Clinical NGS Implementation
Marc S. Williams, M.D., FAAP, FACMG, FACMI, Director, Genomic Medicine Institute, Geisinger Health System

Precision Medicine Outside of Oncology
Jonathan Pan, Ph.D., MBA, Vice President, Head of Biomarker Strategy and Development, Aevi Genomic Medicine, Inc.

Implementing Point-of-Care Testing and Pharmacogenetic Testing in the Community Pharmacy
Edana Holliday, PharmD, Clinical Pharmacist, Community Ambulatory Care Services, Rx Clinic Pharmacy; VP, Communications, Pharmacogenetics Center of Excellence

Genome Sequencing Clinical Applications: What Will it Take to Make NGS Standard of Care?
Liz Worthey, Ph.D., Faculty Investigator, Director, Software Development and Informatics, HudsonAlpha Institute for Biotechnology

Reimbursement of Companion Diagnostics: Discussions for Precision Medicine
Omar Perez, Ph.D., RAC, Director and Diagnostics Lead, Oncology Programs, Worldwide R&D, Pfizer Inc.

Walking Down Evidence Street™: Where the Market Meets Evidence
Suzanne Belinson, Ph.D., Executive Director of Clinical Markets, Blue Cross Blue Shield Association


Combining Whole Genome Sequencing with Clinical Care
David Bick, M.D., CMO & Faculty Investigator, HudsonAlpha Institute for Biotechnology; Founder & CMO, Envision Genomics; Medical Director, Smith Family Clinic for Genomic Medicine

Transitioning Basic Research Into Actual Diagnostics: A Preview
Timothy D. Minogue, Ph.D., Chief, Molecular Diagnostics Department, Diagnostic Systems Division, USAMRIID

Digital PCR: Changing the Way Scientists Conduct Research
Hatim Husain, M.D., Assistant Professor, Medicine, Hematology and Oncology, University of California, San Diego

Medicine for the Future: NGS Pricing and Precision Medicine Implementation in the Clinic
Jamie Platt, Ph.D., MB(ASCP), Managing Director, BRIDGenomics, LLC.

The Microbiome and Human Reproduction: Current Research and Future Developments
Jason Franasiak, M.D., FACOG, Attending Physician, Reproductive Medicine Associates of New Jersey

Blood-Based Genotyping of Colorectal Cancer Patients - Video Interview
Giulia Siravegna, MSc, Ph.D. Student, Molecular Medicine, Oncology, School of Medicine, University of Torino; IRCCS-Candiolo Cancer Institute


Metabolomics for Infectious Disease: A Focus on Sepsis
Raymond J. Langley, Ph.D., Associate Research Scientist, Lovelace Respiratory Research Institute

Biomarkers for Infectious Disease: Current Challenges and Advancements
Kate Simon, Ph.D., Senior Consultant, Biologics Consulting Group, Inc.

Technological Advancements for Diagnostics Sequencing
Reiner Babiel, Ph.D., Executive Director, Consulting, RBDC

POC in the Pharmacy: Practical, Legal, and Future Perspectives
Allison M. Dering-Anderson, BA, Pharm.D., RP, FAAIM, Clinical Assistant Professor, Pharmacy, University of Nebraska College of Pharmacy

Point-of-Care Testing in a Retail Health Clinic Setting
Alexander Sbordone, J.D., Operations Manager, MinuteClinic, CVS Caremark Corporation


Preview of the Panel Discussion on IMPLEMENTATION OF MOLECULAR TESTING: Demonstrating Clinical Utility and Measuring Health Outcomes
Panel of speakers moderated by Julie Lynch, Ph.D., featuring Michael Kelly, M.D., Vickie L. Venne, Donna Polizio and John W. Hanna

Companion Diagnostics – Regulatory Improvements, Market Trends and Emerging Technologies
with Richard A. White, Ph.D., Director, Global Strategy, Breast and Colon Products, Genomic Health, Inc.

Single-Cell Sequencing and Complex Cancer Genome Analysis for Clinical Parameters and Personalized Therapy
with James Hicks, Ph.D., Research Professor, Cancer Genomics, Cold Spring Harbor Laboratory

Incidental Findings, Unwanted Information, and the “Safety” of Genomic Testing
Kimberly Strong, Ph.D., Assistant Professor and Primary Faculty, Program in Genomics and Ethics, Institute for Health and Society - Center for Bioethics and Medical Humanities & Human and Molecular Genetics Center, Medical College of Wisconsin

Single-Cell Genomic Sequencing: Improvements, Challenges and Utility
Jan Vijg, Ph.D., Professor and Chairman, Genetics, Albert Einstein College of Medicine

Integration of Genomics into Medical Practice: Educational Challenges
Bruce Korf, M.D., Ph.D., Wayne H. and Sara Crews Finley Chair, Medical Genetics; Professor and Chair, Genetics; Director, Heflin Center for Genomic Sciences, University of Alabama at Birmingham


Revolutionary Point-of-Care (POC) Diagnostic Technologies to Improve the Prevention, Control and Treatment of Infectious Diseases
Michel G. Bergeron, O.Q., M.D., FRCPC, Director and Founder, Centre de Recherche en Infectiologie de l’Université Laval

POC: The Search for the Holy Grail Continues
Harry Glorikian, Founder and Managing Partner, Scientia Advisors LLC

MALDI-TOF in the Mycobacteriology Laboratory
Nathan A. Ledeboer, Ph.D., Assistant Professor of Pathology, Medical College of Wisconsin

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag  

Premier Sponsor

Boston Healthcare logo(1)  

Register Now


Download 2018 Brochure


Conference At A Glance